DOI:
10.1055/s-00000175
Arzneimittelforschung
LinksClose Window
References
Ricart AD, Tolcher AW, Liu G et al.
Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: A phase I, pharmacokinetic, and biological correlative study.
Clin Cancer Res 2008;
14: 7924-7929
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.